Wealthspire Advisors (New York)’s Labcorp LH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$772K	Sell	2,892 -363	-11%	-$98.3K	0.01%	459
2025 Q4	$817K	Buy	3,255 +1,101	+51%	+$292K	0.01%	474
2025 Q3	$618K	Sell	2,154 -7	-0.3%	-$1.88K	﹤0.01%	487
2025 Q2	$567K	Sell	2,161 -1,596	-42%	-$389K	﹤0.01%	505
2025 Q1	$874K	Sell	3,757 -87	-2%	-$21.1K	0.01%	400
2024 Q4	$882K	Buy	3,844 +233	+6%	+$53.5K	0.01%	397
2024 Q3	$807K	Buy	3,611 +115	+3%	+$25.3K	0.01%	404
2024 Q2	$711K	Sell	3,496 -49	-1%	-$9.97K	0.01%	369
2024 Q1	$774K	Sell	3,545 -62	-2%	-$13.7K	0.01%	349
2023 Q4	$820K	Sell	3,607 -218	-6%	-$45.8K	0.01%	345
2023 Q3	$769K	Sell	3,825 -525	-12%	-$111K	0.01%	322
2023 Q2	$902K	Sell	4,350 -1	-0%	-$194	0.01%	263
2023 Q1	$858K	Sell	4,351 -224	-5%	-$46.1K	0.01%	274
2022 Q4	$925K	Buy	4,575 +56	+1%	+$10.9K	0.02%	276
2022 Q3	$795K	Hold	4,519	–	–	0.02%	260
2022 Q2	$910K	Buy	4,519 +28	+0.6%	+$5.97K	0.02%	220
2022 Q1	$1.02M	Sell	4,491 -341	-7%	-$80.2K	0.02%	194
2021 Q4	$1.3M	Sell	4,832 -333	-6%	-$82.4K	0.03%	194
2021 Q3	$1.25M	Buy	5,165 +665	+15%	+$168K	0.03%	219
2021 Q2	$1.07M	Sell	4,500 -4,704	-51%	-$1.07M	0.03%	157
2021 Q1	$2.02M	Buy	9,204 +4,669	+103%	+$937K	0.05%	173
2020 Q4	$793K	Buy	+4,535	New	+$783K	0.02%	235
2020 Q2	–	Sell	-7,287	Closed	-$791K	–	423
2020 Q1	$791K	Buy	+7,287	New	+$1.05M	0.03%	230
2019 Q1	–	Sell	-151	Closed	-$16K	–	467
2018 Q4	$16K	Buy	+151	New	+$20.2K	﹤0.01%	392

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealthspire Advisors (New York)'s LH Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Labcorp (LH) stake by 11% in Q1 2026, selling an estimated $98.3K and leaving 2,892 shares worth $772K. The position accounts for 0.01% of the portfolio, ranked #459.

Wealthspire Advisors (New York) first reported a position in LH in Q4 2018 and has held it in 24 quarters since. The position peaked at $2.02M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Wealthspire Advisors (New York) held 2,892 shares of Labcorp worth $772K as of Q1 2026.
Wealthspire Advisors (New York) sold 363 Labcorp shares in Q1 2026, an estimated $98.3K.
Labcorp made up 0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #459 holding.
Wealthspire Advisors (New York) first reported a position in Labcorp in Q4 2018 and has held it in 24 quarters since.
Wealthspire Advisors (New York)'s Labcorp position peaked at $2.02M in Q1 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.